Axon Enterprise, Inc. (NASDAQ:AXON) Stock Holdings Lifted by Sigma Planning Corp

Sigma Planning Corp increased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 61.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 1,645 shares of the biotechnology company’s stock after buying an additional 629 shares during the period. Sigma Planning Corp’s holdings in Axon Enterprise were worth $978,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Blue Trust Inc. grew its position in Axon Enterprise by 234.5% in the 3rd quarter. Blue Trust Inc. now owns 291 shares of the biotechnology company’s stock worth $116,000 after purchasing an additional 204 shares during the last quarter. Ballentine Partners LLC acquired a new position in shares of Axon Enterprise during the third quarter worth approximately $293,000. Allworth Financial LP grew its holdings in Axon Enterprise by 7.1% in the 3rd quarter. Allworth Financial LP now owns 1,006 shares of the biotechnology company’s stock worth $402,000 after buying an additional 67 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its position in Axon Enterprise by 23.3% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 6,329 shares of the biotechnology company’s stock valued at $2,502,000 after acquiring an additional 1,196 shares during the period. Finally, Forsta AP Fonden raised its stake in Axon Enterprise by 10.9% during the 3rd quarter. Forsta AP Fonden now owns 15,300 shares of the biotechnology company’s stock valued at $6,114,000 after acquiring an additional 1,500 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on AXON shares. JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. TD Cowen initiated coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price on the stock. Finally, Northland Securities increased their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $561.31.

Insider Activity

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jeffrey C. Kunins sold 2,304 shares of the business’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the completion of the transaction, the insider now directly owns 128,542 shares of the company’s stock, valued at $84,168,016.18. This trade represents a 1.76 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 8,711 shares of company stock valued at $5,631,561. 5.70% of the stock is currently owned by insiders.

Axon Enterprise Price Performance

Shares of AXON stock opened at $496.65 on Wednesday. Axon Enterprise, Inc. has a 1 year low of $265.32 and a 1 year high of $715.99. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The firm’s 50 day moving average is $614.17 and its 200-day moving average is $521.71. The firm has a market capitalization of $37.87 billion, a price-to-earnings ratio of 128.33, a PEG ratio of 5.17 and a beta of 1.05.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.